Themis Bioscience Overview
- Year Founded
-
2009
- Status
-
Acquired/Merged
- Employees
-
40
- Latest Deal Type
-
M&A
- Latest Deal Amount
-
$1.11B
Themis Bioscience General Information
Description
Themis Bioscience NV is an immunomodulation clinical-stage biopharmaceutical group that focuses on the development of products to protect against infectious diseases and for the treatment of cancer. The company has developed a vaccine platform and broad pipeline based on the advanced understanding of immune system mechanisms.
Contact Information
Website
www.themisbio.comCorporate Office
- Muthgasse 11/2
- Vienna, 1190
- Austria
Corporate Office
- Muthgasse 11/2
- Vienna, 1190
- Austria
Themis Bioscience Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 12. Merger/Acquisition | 19-Jun-2020 | $1.11B | Completed | Generating Revenue | ||
| 11. IPO | 29-Apr-2020 | Cancelled | Clinical Trials - Phase 2 | |||
| 10. Later Stage VC (Series D) | 18-Sep-2019 | Completed | Generating Revenue | |||
| 9. Grant | 04-Jun-2019 | Completed | Generating Revenue | |||
| 8. Grant | 06-Mar-2018 | Completed | Clinical Trials - Phase 2 | |||
| 7. Later Stage VC (Series C) | 04-Jan-2018 | Completed | Clinical Trials - Phase 2 | |||
| 6. Later Stage VC (Series B) | 29-Nov-2016 | Completed | Clinical Trials - Phase 2 | |||
| 5. Secondary Transaction - Private | 01-Oct-2013 | Completed | Startup | |||
| 4. Early Stage VC (Series A) | 18-May-2011 | $7.24M | $8.61M | Completed | Startup | |
| 3. Grant | 06-Jul-2010 | $1.23M | $1.37M | Completed | Startup |
Themis Bioscience Comparisons
Industry
Financing
Details
Themis Bioscience Competitors (33)
One of Themis Bioscience’s 33 competitors is Arbutus Biopharma, a Corporation company based in Warminster, PA.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Arbutus Biopharma | Corporation | Warminster, PA | ||||
| Xenetic Biosciences | Corporation | Framingham, MA | ||||
| Agenus | Formerly VC-backed | Lexington, MA | ||||
| Intellia Therapeutics | Formerly VC-backed | Cambridge, MA | ||||
| Circle Pharma | Venture Capital-Backed | South San Francisco, CA |
Themis Bioscience Patents
Themis Bioscience Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| FR-3119919-A1 | Electric battery rental device and associated assembly | Inactive | 18-Feb-2021 | ||
| WO-2022175393-A1 | Electric battery rental device and associated assembly | Inactive | 18-Feb-2021 | ||
| WO-2022038140-A1 | Co-stimulatory 4-1bbl ectodomain polypeptides for immunomodulation | Inactive | 17-Aug-2020 | ||
| EP-3673917-A1 | Norovirus vaccines | Inactive | 28-Dec-2018 | ||
| WO-2020136282-A1 | Norovirus vaccines | Inactive | 28-Dec-2018 | A61K39/295 |
Themis Bioscience Signals
Themis Bioscience Former Investors (14)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Adjuvant Capital | Impact Investing | Minority | ||
| Austria Wirtschaftsservice | Venture Capital | Minority | ||
| Coalition for Epidemic Preparedness Innovations | Impact Investing | |||
| FFG Finanzierungs- und Factorings | Corporation | Minority | ||
| Farallon Capital Management | Hedge Fund | Minority |
Themis Bioscience FAQs
-
When was Themis Bioscience founded?
Themis Bioscience was founded in 2009.
-
Where is Themis Bioscience headquartered?
Themis Bioscience is headquartered in Vienna, Austria.
-
What is the size of Themis Bioscience?
Themis Bioscience has 40 total employees.
-
What industry is Themis Bioscience in?
Themis Bioscience’s primary industry is Biotechnology.
-
Is Themis Bioscience a private or public company?
Themis Bioscience is a Private company.
-
What is the current valuation of Themis Bioscience?
The current valuation of Themis Bioscience is .
-
What is Themis Bioscience’s current revenue?
The current revenue for Themis Bioscience is .
-
How much funding has Themis Bioscience raised over time?
Themis Bioscience has raised $75.5M.
-
Who are Themis Bioscience’s investors?
Adjuvant Capital, Austria Wirtschaftsservice, Coalition for Epidemic Preparedness Innovations, FFG Finanzierungs- und Factorings, and Farallon Capital Management are 5 of 14 investors who have invested in Themis Bioscience.
-
Who are Themis Bioscience’s competitors?
Arbutus Biopharma, Xenetic Biosciences, Agenus, Intellia Therapeutics, and Circle Pharma are some of the 33 competitors of Themis Bioscience.
-
When was Themis Bioscience acquired?
Themis Bioscience was acquired on 19-Jun-2020.
-
Who acquired Themis Bioscience?
Themis Bioscience was acquired by Merck & Co..
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process